Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. LYEL
LYEL logo

LYEL News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

LYEL News

Lyell Immunopharma Releases New Data on Ronde-cel Therapy

5d agoNewsfilter

LYL273 Clinical Trial Safety Update

Jun 08 2026Newsfilter

Lyell Immunopharma Reports Reduced Q1 Net Loss

May 06 2026seekingalpha

Lyell Immunopharma Reports $140.7M Q4 Loss Amid Acquisition Costs

Mar 12 2026seekingalpha

Lyell Immunopharma Launches PiNACLE-H2H Clinical Trial for Ronde-cel

Feb 12 2026Newsfilter

Mineralys Therapeutics Shares Surge 203.4%, NDA Submission Expected in 2026

Dec 26 2025NASDAQ.COM

GT Biopharma Advances GTB-3650 Clinical Trial to Cohort 4 with 10μg/kg/day Dosing

Dec 24 2025Globenewswire

Lyell Immunopharma Soars Following Recent ASH Data and Immunotherapy Growth

Dec 22 2025SeekingAlpha

LYEL Events

No data

No data

LYEL Monitor News

No data

No data

LYEL Earnings Analysis

No Data

No Data

People Also Watch